| Overview |
| bsm-62541r-rbitc-100ul |
| CAPD2 Recombinant Antibody, RBITC Conjugated |
| WB |
| Human |
| Specifications |
| RBITC |
| Rabbit |
| KLH conjugated synthetic peptide derived from human Condensin complex subunit 1 |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 9918 |
| Q15021 |
| Cytoplasm, Nucleus |
| CAPD2; CEP2; CEP250; CNAP1; CND1; Condensin; hCAPD2; NCAPD2. |
| Regulatory subunit of the condensin complex, a complex required for conversion of interphase chromatin into mitotic-like condense chromosomes. The condensin complex probably introduces positive supercoils into relaxed DNA in the presence of type I topoisomerases and converts nicked DNA into positive knotted forms in the. presence of type II topoisomerases. May target the condensin complex to DNA via its C-terminal domain |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz